Anzeige
Mehr »
Donnerstag, 12.02.2026 - Börsentäglich über 12.000 News
Top-Ergebnisse: 1,75 g/t Gold über 30,4 Meter + massives Tagebau-Potenzial
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
8 Leser
Artikel bewerten:
(0)

Rutger Oudejans Appointed Brand Director of UBM Pharma Portfolio

AMSTERDAM, April 16, 2014 /PRNewswire/ --

Responsibilities will include widening the brand's global reach and continuing CPhI Worldwide event expansion

CPhI Worldwide, part of UBM Live, has announced the appointment of Rutger Oudejans to the role of Brand Director of the UBM Pharma Portfolio. Central to the role is responsibility for the strategic development of UBM's Pharmaceutical brands (CPhI, ICSE, Inno-Pack and P-MEC), communities (CPhI Online), content (CPhI annual report), products and services.

(Logo: http://photos.prnewswire.com/prnh/20130723/629764-a )

Rutger will primarily be responsible for the flagship CPhI Worldwide event taking place in Paris this year. He has tasked himself with expanding the brand's exposure within the established Western markets, whilst also cementing attendance from an increasing number of emerging markets.

Oudejans will also continue to grow CPhI Worldwide's Pre-Connect conference platform and the well-respected CPhI Pharma Awards, which recognise industry's biggest innovations. He is a creative, strategic and highly experienced leader, who brings hands-on pharmaceutical industry knowledge to the position, having undertaken previous roles in Asia focusing on functional excipients and formerly representing UBM's pharma division for several years.

Commenting on his appointment, Oudejans remarked: "I am delighted to be taking on this position within the Pharma division at UBM Live and I look forward to leadingthe delivery of CPhI's flagship Worldwide event. This year, we will continue to expand the event with increased exhibitors and attendees from across the globe, as well as launching the second edition of the annual report, alongside the successful custom matchmaking, innovation tours and free seminars."

About CPhI

CPhI drives growth and innovation at every step of the global pharmaceutical supply chain from drug discovery to finished dosage. Through exhibitions, conferences and online communities, CPhI brings together more than 100,000 pharmaceutical professionals each year to network, identify business opportunities and expand the global market. CPhI hosts events in Europe, China, India, Japan, Southeast Asia, Istanbul, Russia and South America and co-locates with ICSE for contract services, P-MEC for machinery, equipment & technology, InnoPack for pharmaceutical packaging and BioPh for biopharma. CPhI provides an online buyer & supplier directory at CPhI-Online.com.

For more information visit: http://www.cphi.com

The UBM Live annual schedule of Pharmaceutical events also includes CPhI Russia and IPhEB (16-17 April, 2014 at the Lenexpo Exhibition Complex - St Petersburg, Russia); CPhI, P-MEC and Innopack South East Asia (20-22 May, 2014 at the Jakarta International Expo - Jakarta, Indonesia); CPhI Istanbul (4-6 June, 2014, at the Lutfi Kirdar Convention and Exhibition Centre - Turkey); CPhI, Hi and Fi, ICSE, P-MEC, BioPh and LabWorld China (26-28 June, 2014 at SNIEC- Shanghai, China); CPhI South America (5-7 August 2014 at Expo Centre Norte, Sao Paulo - Brazil); CPhI, ICSE Korea (2-3 September, 2014 at the COEX - Seoul, South Korea); CPhI, ICSE, P-MEC and InnoPack Worldwide (7-9 October 2014, Paris Nord Villepinte - France); CPhI and P-MEC India (2-4 December, 2014 at the Bombay Exhibition Centre - Mumbai); CPhI, ICSE, P-MEC, BioPh and Pharmatec Japan (22-24 April, 2015 at the Big Sight Exhibition Centre - Tokyo).

About UBM Live

UBM Live connects people and creates opportunities for companies across five continents to develop new business, meet customers, launch new products, promote their brands, and expand their market. Through premier brands such as TFM&A, Internet World, IFSEC, MD&M, CPhI, Cruise Shipping Miami, the Concrete Show, and many others, UBM Live exhibitions, conferences, awards programs, publications, Websites, and training and certification programs are an integral part of the marketing plans of companies across more than 20 industry sectors.

For media enquiries, please contact:
Alex Heeley or Tristan Jervis
De Facto Communications
T: +44-207-203-6745 / 6740
E: a.heeley@defacto.com / t.jervis@defacto.com


© 2014 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.